Trending Stock News

Ghost Tree Capital Position in Neurocrine Biosciences (NBIX) Has Upped as Shares Rose; Majedie Asset Management LTD Holds Holding in Sohu Com (SOHU)

Majedie Asset Management Ltd increased its stake in Sohu Com Inc (SOHU) by 29.42% based on its latest 2017Q3 regulatory filing with the SEC. Majedie Asset Management Ltd bought 58,071 shares as the company’s stock rose 17.23% with the market. The institutional investor held 255,452 shares of the edp services company at the end of 2017Q3, valued at $13.91 million, up from 197,381 at the end of the previous reported quarter. Majedie Asset Management Ltd who had been investing in Sohu Com Inc for a number of months, seems to be bullish on the $1.34B market cap company. The stock decreased 1.06% or $0.37 during the last trading session, reaching $34.5. About 305,238 shares traded. Sohu.com Inc. (NASDAQ:SOHU) has risen 19.17% since February 19, 2017 and is uptrending. It has outperformed by 2.47% the S&P500.

Ken Greenberg increased its stake in Neurocrine Biosciences Inc (NBIX) by 50% based on its latest 2017Q3 regulatory filing with the SEC. Ghost Tree Capital Llc bought 75,000 shares as the company’s stock rose 19.84% with the market. The hedge fund run by Ken Greenberg held 225,000 shares of the health care company at the end of 2017Q3, valued at $13.79M, up from 150,000 at the end of the previous reported quarter. Ghost Tree Capital Llc who had been investing in Neurocrine Biosciences Inc for a number of months, seems to be bullish on the $7.61B market cap company. The stock decreased 0.37% or $0.32 during the last trading session, reaching $85.25. About 855,438 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 12.51% since February 19, 2017 and is uptrending. It has underperformed by 4.19% the S&P500.

Among 13 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 47 analyst reports since August 18, 2015 according to SRatingsIntel. The rating was maintained by Oppenheimer with “Buy” on Wednesday, February 14. The firm has “Buy” rating given on Thursday, November 3 by Deutsche Bank. The stock of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has “Buy” rating given on Friday, August 4 by H.C. Wainwright. BMO Capital Markets maintained it with “Buy” rating and $84.0 target in Tuesday, October 3 report. On Tuesday, November 14 the stock rating was maintained by Oppenheimer with “Buy”. The firm has “Buy” rating by Robert W. Baird given on Monday, October 23. As per Tuesday, July 11, the company rating was maintained by H.C. Wainwright. Deutsche Bank maintained it with “Buy” rating and $79.0 target in Thursday, November 2 report. The rating was upgraded by Oppenheimer to “Outperform” on Friday, January 27. The stock has “Buy” rating by Cowen & Co on Friday, October 27.

Investors sentiment increased to 1.66 in 2017 Q3. Its up 0.41, from 1.25 in 2017Q2. It improved, as 22 investors sold NBIX shares while 45 reduced holdings. 32 funds opened positions while 79 raised stakes. 92.69 million shares or 0.83% more from 91.92 million shares in 2017Q2 were reported. Moreover, Blackrock has 0.02% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Eam Invsts Lc has invested 0.32% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Quantitative Systematic Strategies Lc reported 0.08% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). New York-based Davidson Kempner Capital Mgmt Lp has invested 0.22% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Swiss Retail Bank stated it has 0.01% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). California Public Employees Retirement holds 0.02% or 181,900 shares. Weiss Asset Mgmt Lp has invested 0.02% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Redmile Grp Inc Ltd Liability Corp has invested 0.02% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Raymond James Associates invested in 0% or 22,676 shares. Cubist Systematic Strategies Limited Co has invested 0.01% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Vanguard Group Inc stated it has 0.02% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Stifel, a Missouri-based fund reported 4,029 shares. Deutsche National Bank Ag reported 1.45 million shares. Aperio Limited Liability holds 0.01% or 21,912 shares. Jennison Associate Limited Liability Corporation stated it has 321,145 shares or 0.02% of all its holdings.

Ghost Tree Capital Llc, which manages about $470.91M US Long portfolio, decreased its stake in Ptc Therapeutics Inc (NASDAQ:PTCT) by 100,000 shares to 100,000 shares, valued at $2.00 million in 2017Q3, according to the filing. It also reduced its holding in Aimmune Therapeutics Inc (Call) by 100,000 shares in the quarter, leaving it with 150,000 shares, and cut its stake in Axovant Sciences Ltd.

Since September 5, 2017, it had 0 buys, and 24 sales for $26.58 million activity. $169,914 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares were sold by Gano Kyle. Another trade for 18,084 shares valued at $1.40 million was sold by Lloyd-Smith Malcolm. $1.58 million worth of stock was sold by Bozigian Haig P. on Wednesday, September 6. $169,997 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares were sold by Grigoriadis Dimitri E.. 2,737 shares were sold by Lippoldt Darin, worth $227,494. GORMAN KEVIN CHARLES sold $8.50 million worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Monday, February 5.

Majedie Asset Management Ltd, which manages about $1.23 billion US Long portfolio, decreased its stake in Oracle Corp (NYSE:ORCL) by 27,834 shares to 212,817 shares, valued at $10.29 million in 2017Q3, according to the filing. It also reduced its holding in Hollysys Automation Technolo (NASDAQ:HOLI) by 258,077 shares in the quarter, leaving it with 671,293 shares, and cut its stake in Facebook Inc (NASDAQ:FB).

Among 7 analysts covering Sohu.com Inc. (NASDAQ:SOHU), 1 have Buy rating, 2 Sell and 4 Hold. Therefore 14% are positive. Sohu.com Inc. had 7 analyst reports since October 8, 2015 according to SRatingsIntel. As per Wednesday, August 31, the company rating was reinitiated by JP Morgan. The firm has “Hold” rating by Deutsche Bank given on Monday, October 30. The firm earned “Neutral” rating on Friday, July 22 by Citigroup. The company was upgraded on Tuesday, August 1 by Morgan Stanley. Macquarie Research maintained the shares of SOHU in report on Monday, October 19 with “Neutral” rating. Goldman Sachs downgraded the shares of SOHU in report on Monday, November 30 to “Sell” rating.

Investors sentiment increased to 1.47 in 2017 Q3. Its up 0.08, from 1.39 in 2017Q2. It increased, as 13 investors sold SOHU shares while 19 reduced holdings. 19 funds opened positions while 28 raised stakes. 18.85 million shares or 3.07% more from 18.29 million shares in 2017Q2 were reported. Hbk Invs Limited Partnership invested in 24,634 shares. Moreover, Deutsche Bancorp Ag has 0.02% invested in Sohu.com Inc. (NASDAQ:SOHU). Css Ltd Il has invested 0.02% in Sohu.com Inc. (NASDAQ:SOHU). Bnp Paribas Arbitrage Sa has invested 0% in Sohu.com Inc. (NASDAQ:SOHU). State Street Corp reported 0% in Sohu.com Inc. (NASDAQ:SOHU). Aqr Cap Mngmt Limited Com accumulated 0% or 18,051 shares. D E Shaw & Inc reported 0.01% of its portfolio in Sohu.com Inc. (NASDAQ:SOHU). Us State Bank De has 0% invested in Sohu.com Inc. (NASDAQ:SOHU) for 1,693 shares. Bankshares Of America De holds 0% or 76,396 shares in its portfolio. 46,779 are owned by First Trust Advisors L P. 4,735 were reported by Wells Fargo Com Mn. Gsa Partners Llp reported 0.21% in Sohu.com Inc. (NASDAQ:SOHU). Strs Ohio holds 0.04% or 180,200 shares. Barclays Public Ltd Co invested in 50,218 shares or 0% of the stock. Quantitative Management Ltd Co invested in 51,000 shares.

Leave a Reply

Your email address will not be published. Required fields are marked *